Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study
Authors:
- 12 May 2023
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 174, 133-141
Abstract
No abstract availableKeywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: A prospective cross-sectional studyGynecologic Oncology, 2014
- Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)European Journal of Cancer, 2013
- Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10BMJ, 2012
- Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic reviewGynecologic Oncology, 2012
- CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trialsInternational Journal of Surgery, 2012
- Progestogen treatment options for early endometrial cancerBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine systemHuman Reproduction, 2010
- Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-upMaturitas, 2007
- The metabolic syndromeThe Lancet, 2005
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUDClinical Endocrinology, 1982